Norges Bank’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,000	Closed	-$792K	–	2125
2019 Q2	$792K	Buy	+60,000	New	+$792K	﹤0.01%	2044